Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H16N2S.BrH |
Molecular Weight | 349.289 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.CC1=CC=C(C=C1)C2=CN3C(SC4=C3CCCC4)=N2
InChI
InChIKey=SGNCOAOESGSEOP-UHFFFAOYSA-N
InChI=1S/C16H16N2S.BrH/c1-11-6-8-12(9-7-11)13-10-18-14-4-2-3-5-15(14)19-16(18)17-13;/h6-10H,2-5H2,1H3;1H
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/24646317Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21362431 | https://www.ncbi.nlm.nih.gov/pubmed/21324703
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24646317
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21362431 | https://www.ncbi.nlm.nih.gov/pubmed/21324703
Pifithrin-alpha is a small molecule p53 functional inhibitor reported to behave like an antiapoptotic agent in neurodegenerative models. Pifithrin-alpha is a prodrug that under physiological conditions
spontaneously undergoes ring closure to yield pifithrin-beta. Pifithrin-beta demonstrated antiproliferative and neuroprotective effects in vitro. Pifithrin-beta is able to activate the aryl hydrocarbon receptor (AhR) in a complete independent way of the p53 inhibition.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10481009 | http://adisinsight.springer.com/drugs/800012866
Curator's Comment: Pifithrin-beta is cyclic Pifithrin-alpha, Pifithrin-alpha first described by Komarov et al
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3201 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21362431 |
|||
Target ID: CHEMBL4164 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism. | 2006 Jun 15 |
|
p53 functional inhibitors behaving like pifithrin-β counteract the Alzheimer peptide non-β-amyloid component effects in human SH-SY5Y cells. | 2014 May 21 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24646317
10 μM pifithrin-β prevented apoptosis induced by the fibrillar non-β-amyloid component in human neuroblastoma SH-SY5Y cells
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
UP003XXT4D
Created by
admin on Sat Dec 16 09:52:47 GMT 2023 , Edited by admin on Sat Dec 16 09:52:47 GMT 2023
|
PRIMARY | |||
|
511296-88-1
Created by
admin on Sat Dec 16 09:52:47 GMT 2023 , Edited by admin on Sat Dec 16 09:52:47 GMT 2023
|
PRIMARY | |||
|
DTXSID301010188
Created by
admin on Sat Dec 16 09:52:47 GMT 2023 , Edited by admin on Sat Dec 16 09:52:47 GMT 2023
|
PRIMARY | |||
|
11515812
Created by
admin on Sat Dec 16 09:52:47 GMT 2023 , Edited by admin on Sat Dec 16 09:52:47 GMT 2023
|
PRIMARY | |||
|
m8803
Created by
admin on Sat Dec 16 09:52:47 GMT 2023 , Edited by admin on Sat Dec 16 09:52:47 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD